Home/Filings/4/0001562180-21-005865
4//SEC Filing

Hordo Christian 4

Accession 0001562180-21-005865

CIK 0001770121other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 7:29 PM ET

Size

16.3 KB

Accession

0001562180-21-005865

Insider Transaction Report

Form 4
Period: 2021-09-02
Hordo Christian
SVP, Chief Business Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-09-02$1.48/sh+6,558$9,706977,356 total
  • Sale

    Common Stock

    2021-09-02$25.00/sh1,400$35,005969,398 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-09-026,558128,708 total
    Exercise: $1.48Exp: 2030-01-26Common Stock (6,558 underlying)
  • Sale

    Common Stock

    2021-09-02$25.00/sh6,558$163,962970,798 total
  • Sale

    Common Stock

    2021-09-03$25.00/sh700$17,500969,398 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-09-03700128,008 total
    Exercise: $1.48Exp: 2030-01-26Common Stock (700 underlying)
  • Exercise/Conversion

    Common Stock

    2021-09-03$1.48/sh+700$1,036970,098 total
Footnotes (4)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.015, inclusive.
  • [F4]This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter.

Issuer

Sana Biotechnology, Inc.

CIK 0001770121

Entity typeother

Related Parties

1
  • filerCIK 0001830070

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 7:29 PM ET
Size
16.3 KB